Takara Bio Europe Goes Direct in 2012
Clontech owner demonstrates confidence in European research market by establishing wholly-owned sales organisation
Takara Bio Europe has sold Clontech brand products directly to its customers since 2006 but has been using a number of distributors for its Takara brand. The company now intends to sell its wider range of innovative life science reagents and assays via an expanded, dedicated sales team.
Takara Bio Europe’s president, Dr Jean-Jacques Farhi explained that there were a number of compelling reasons behind the move: “Firstly, whilst our distributors have done an excellent job, we felt that we wanted to be more directly involved with our customers since this is a field that relies on feedback for product innovation. Globally, Takara Bio is also growing significantly and we felt the time was right to enhance our direct sales offering. We are seeing high demand for our PCR range in Europe, and qPCR in particular, for exacting applications such as plant genomics and ancient DNA amplification.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.